192 related articles for article (PubMed ID: 1432936)
21. What's next after 50 years of psychiatric drug development: an FDA perspective.
Laughren TP
J Clin Psychiatry; 2010 Sep; 71(9):1196-204. PubMed ID: 20923624
[TBL] [Abstract][Full Text] [Related]
22. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
Orlando VI
Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
[No Abstract] [Full Text] [Related]
23. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
[TBL] [Abstract][Full Text] [Related]
24. FDA's proposed rules on patent listing requirements for new drug and 30-month stays on ANDA approval (proposed Oct. 24, 2002).
Hui YF
Ann Health Law; 2003; 12(2):325-40, table of contents. PubMed ID: 12856462
[TBL] [Abstract][Full Text] [Related]
25. How drugs are developed and approved by the FDA: current process and future directions.
Ciociola AA; Cohen LB; Kulkarni P;
Am J Gastroenterol; 2014 May; 109(5):620-3. PubMed ID: 24796999
[TBL] [Abstract][Full Text] [Related]
26. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
[TBL] [Abstract][Full Text] [Related]
27. FDA review divisions: performance levels and the impact on drug sponsors.
Milne CP; Kaitin KI
Clin Pharmacol Ther; 2012 Mar; 91(3):393-404. PubMed ID: 22336592
[TBL] [Abstract][Full Text] [Related]
28. Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.
Thomadsen BR; Heaton HT; Jani SK; Masten JP; Napolitano ME; Ouhib Z; Reft CS; Rivard MJ; Robin TT; Subramanian M; Suleiman OH
Med Phys; 2010 May; 37(5):2300-11. PubMed ID: 20527564
[TBL] [Abstract][Full Text] [Related]
29. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
[TBL] [Abstract][Full Text] [Related]
30. Walking the drug regulatory tightrope.
Dove A
Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
[No Abstract] [Full Text] [Related]
31. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251
[TBL] [Abstract][Full Text] [Related]
32. Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program.
Galluppi GR; Brar S; Caro L; Chen Y; Frey N; Grimm HP; Rudd DJ; Li CC; Magee M; Mukherjee A; Nagao L; Purohit VS; Roy A; Salem AH; Sinha V; Suleiman AA; Taskar KS; Upreti VV; Weber B; Cook J
Clin Pharmacol Ther; 2021 Nov; 110(5):1172-1175. PubMed ID: 33991429
[No Abstract] [Full Text] [Related]
33. Lessons from innovation in drug-device combination products.
Couto DS; Perez-Breva L; Saraiva P; Cooney CL
Adv Drug Deliv Rev; 2012 Jan; 64(1):69-77. PubMed ID: 22200650
[TBL] [Abstract][Full Text] [Related]
34. OTC or not OTC--that is the question.
Parmley WW
J Am Coll Cardiol; 2000 Oct; 36(4):1426-7. PubMed ID: 11028505
[No Abstract] [Full Text] [Related]
35. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
36. Anorectal drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Aug; 68(165):51167-70. PubMed ID: 12952012
[TBL] [Abstract][Full Text] [Related]
37. US FDA's safety monitoring of drugs with expedited approval.
Furlow B
Lancet Oncol; 2016 Mar; 17(3):281. PubMed ID: 26831290
[No Abstract] [Full Text] [Related]
38. Pro-free enterprise group challenges FDA's authority to regulate drug companies' speech.
Skolnick AA
JAMA; 1994 Feb; 271(5):332, 335. PubMed ID: 8283568
[No Abstract] [Full Text] [Related]
39. Over-the-counter antidiarrheal medications used for the self-treatment of acute nonspecific diarrhea.
Dukes GE
Am J Med; 1990 Jun; 88(6A):24S-26S. PubMed ID: 2356846
[TBL] [Abstract][Full Text] [Related]
40. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
